Calcium promotes vascular smooth muscle cell phenotypic switching in Marfan syndrome

被引:1
作者
Yang, Yunxiao [1 ]
Xie, Enzehua [2 ]
Liu, Yuhua [1 ]
Peng, Zhan [1 ]
Yu, Cuntao [2 ]
Hua, Kun [1 ]
Yang, Xiubin [1 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, Beijing 100029, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiovasc Surg, Beijing 100047, Peoples R China
关键词
Marfan syndrome; Vascular smooth muscle cell; Phenotypic switching; Calcium; AORTIC-ANEURYSM; PROLIFERATION; SERCA;
D O I
10.1016/j.bbrc.2023.05.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibrillin 1 (Fbn1) mutations cause Marfan syndrome (MFS), with aortic root dilatation, dissection, and rupture. Few studies reported the blood calcium and lipid profile of MFS, and the effect of vascular smooth muscle cell (VSMC) phenotypic switching on MFS aortic aneurysm is unclear. Here, we aimed to investigate the role of calcium-related VSMC phenotypic switching in MFS. We retrospectively collected MFS patients' clinical data, performed bioinformatics analysis to screen the enriched biological process in MFS patients and mice, and detected markers of VSMC phenotypic switching on Fbn1C1039G/ thorn mice and primary aortic vascular smooth muscle cells. We found that patients with MFS have elevated blood calcium levels and dyslipidemia. Furthermore, the calcium concentration levels were increased with age in MFS mice, accompanied by the promoted VSMC phenotypic switching, and SERCA2 contributed to maintaining the contractile phenotype of VSMCs. This study provides the first evidence that the increased calcium is associated with the promoted VSMC phenotype switching in MFS. SERCA may become a novel therapeutic target for suppressing aneurysm progression in MFS. (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:124 / 132
页数:9
相关论文
共 36 条
  • [1] Triglyceride Metabolism in the Liver
    Alves-Bezerra, Michele
    Cohen, David E.
    [J]. COMPREHENSIVE PHYSIOLOGY, 2018, 8 (01) : 1 - 22
  • [2] Inhibition of HIPK2 Alleviates Thoracic Aortic Disease in Mice With Progressively Severe Marfan Syndrome
    Caescu, Cristina, I
    Hansen, Jens
    Crockett, Brittany
    Xiao, Wenzhen
    Arnaud, Pauline
    Spronck, Bart
    Weinberg, Alan
    Hashimoto, Takeshi
    Murtada, Sae-Il
    Borkar, Roshan
    Gallo, James M.
    Jondeau, Guillaume
    Boileau, Catherine
    Humphrey, Jay D.
    He, John Cijiang
    Iyengar, Ravi
    Ramirez, Francesco
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (09) : 2483 - 2493
  • [3] Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation
    Choi, Seung Hee
    Park, Sungmi
    Oh, Chang Joo
    Leem, Jaechan
    Park, Keun-Gyu
    Lee, In-Kyu
    [J]. VASCULAR PHARMACOLOGY, 2015, 73 : 11 - 19
  • [4] Dimorphic Effects of Transforming Growth Factor-β Signaling During Aortic Aneurysm Progression in Mice Suggest a Combinatorial Therapy for Marfan Syndrome
    Cook, Jason R.
    Clayton, Nicholas P.
    Carta, Luca
    Galatioto, Josephine
    Chiu, Emily
    Smaldone, Silvia
    Nelson, Carol A.
    Cheng, Seng H.
    Wentworth, Bruce M.
    Ramirez, Francesco
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (04) : 911 - U195
  • [5] A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome
    Doyle, Jefferson J.
    Doyle, Alexander J.
    Wilson, Nicole K.
    Habashi, Jennifer P.
    Bedja, Djahida
    Whitworth, Ryan E.
    Lindsay, Mark E.
    Schoenhoff, Florian
    Myers, Loretha
    Huso, Nick
    Bachir, Suha
    Squires, Oliver
    Rusholme, Benjamin
    Ehsan, Hamid
    Huso, David
    Thomas, Craig J.
    Caulfield, Mark J.
    Van Eyk, Jennifer E.
    Judge, Daniel P.
    Dietz, Harry C.
    [J]. ELIFE, 2015, 4
  • [6] 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases (vol 35, pg 2873, 2014)
    Erbel, R.
    Aboyans, V.
    Boileau, C.
    Bossone, E.
    Di Bartolomeo, R.
    Eggebrecht, H.
    Evangelista, A.
    Falk, V.
    Frank, H.
    Gaemperli, O.
    Grabenwoger, M.
    Haverich, A.
    Iung, B.
    Manolis, A. John
    Meijboom, F.
    Nienaber, C. A.
    Roffi, Marco
    Rousseau, H.
    Sechtem, U.
    Sirnes, Per A.
    Von Allmen, R. S.
    Vrints, C. J. M.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (41) : 2779 - 2779
  • [7] MARFAN-SYNDROME - LONG-TERM SURVIVAL AND COMPLICATIONS AFTER AORTIC-ANEURYSM REPAIR
    FINKBOHNER, R
    JOHNSTON, D
    CRAWFORD, ES
    COSELLI, J
    MILEWICZ, DM
    [J]. CIRCULATION, 1995, 91 (03) : 728 - 733
  • [8] Preparation of primary cultured mesenteric artery smooth muscle cells for fluorescent imaging and physiological studies
    Golovina, Vera A.
    Blaustein, Mordecai P.
    [J]. NATURE PROTOCOLS, 2006, 1 (06) : 2681 - 2687
  • [9] Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm A Meta-analysis
    Harrison, Seamus C.
    Holmes, Michael V.
    Burgess, Stephen
    Asselbergs, Folkert W.
    Jones, Gregory T.
    Baas, Annette F.
    van 't Hof, F. N.
    de Bakker, Paul I. W.
    Blankensteijn, Jan D.
    Powell, Janet T.
    Saratzis, Athanasios
    de Borst, Gert J.
    Swerdlow, Daniel I.
    van der Graaf, Yolanda
    van Rij, Andre M.
    Carey, David J.
    Elmore, James R.
    Tromp, Gerard
    Kuivaniemi, Helena
    Sayers, Robert D.
    Samani, Nilesh J.
    Bown, Matthew J.
    Humphries, Steve E.
    [J]. JAMA CARDIOLOGY, 2018, 3 (01) : 26 - 33
  • [10] Role of Cholesterol-Associated Steatohepatitis in the Development of NASH
    Horn, Christian L.
    Morales, Amilcar L.
    Savard, Christopher
    Farrell, Geoffrey C.
    Ioannou, George N.
    [J]. HEPATOLOGY COMMUNICATIONS, 2022, 6 (01) : 12 - 35